Skip to main content

Online Exclusive

At AAD VMX 2021, Esther Freeman, MD, PhD, shared updates from the COVID-19 Dermatology Registry, emphasizing reassuring evidence that COVID-19 vaccines are safe and well-tolerated in terms of skin reactions.
What has the shift to virtual over the past year meant for dermatology and its patients? In an interview with The Dermatologist, Shadi Kourosh MD, MPH, FAAD, answered questions about her recent look into “Zoom dysmorphia” and its negative effects.
Jessica Garlewicz, Associate Digital Editor
Todd Schlesinger, MD, FAAD, FASMS, spoke to The Dermatologist about his session at AAD VMX 2021 titled "Managing Advanced Non-Melanoma Skin Cancer."
Dr Brett King discussed alopecia areata and its treatment in a presentation prior to the Interdisciplinary Autoimmune Summit 2021.
Erin Wei, MD, discusses Pemphigus Vulgaris prior to her IAS session titled Pemphigus Vulgaris: Strategies for Disease Identification and Management.
At the Interdisciplinary Autoimmune Summit 2021, Dr Lio spoke about emerging therapies for moderate to severe AD. In an interview with ALN, he answered several questions regarding advanced management of the disease.
Back to Top